MX2008010233A - Composicion de liberacion modificada, que comprende doxofilina. - Google Patents

Composicion de liberacion modificada, que comprende doxofilina.

Info

Publication number
MX2008010233A
MX2008010233A MX2008010233A MX2008010233A MX2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A MX 2008010233 A MX2008010233 A MX 2008010233A
Authority
MX
Mexico
Prior art keywords
doxofylline
modified release
release composition
pharmaceutically
derivative
Prior art date
Application number
MX2008010233A
Other languages
English (en)
Spanish (es)
Inventor
Frederick Van Gulik
Madhusudan Rao Yamsani
Ramesh Gannu
Suresh Bandari
Bodapunti Prabha Shakar
Original Assignee
Eurodrug Lab B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodrug Lab B V filed Critical Eurodrug Lab B V
Publication of MX2008010233A publication Critical patent/MX2008010233A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
MX2008010233A 2008-03-10 2008-03-10 Composicion de liberacion modificada, que comprende doxofilina. MX2008010233A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2008/000554 WO2009112874A1 (en) 2008-03-10 2008-03-10 Modified release composition comprising doxofylline

Publications (1)

Publication Number Publication Date
MX2008010233A true MX2008010233A (es) 2009-11-10

Family

ID=40084194

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2008010233A MX2008010233A (es) 2008-03-10 2008-03-10 Composicion de liberacion modificada, que comprende doxofilina.
MX2010009917A MX2010009917A (es) 2008-03-10 2009-03-06 Composicion de liberacion modificada que comprende doxofilina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2010009917A MX2010009917A (es) 2008-03-10 2009-03-06 Composicion de liberacion modificada que comprende doxofilina.

Country Status (7)

Country Link
EP (1) EP2262485A1 (it)
KR (1) KR101697773B1 (it)
AU (1) AU2009224801B2 (it)
BR (1) BRPI0906158B8 (it)
IT (1) ITMI20080798A1 (it)
MX (2) MX2008010233A (it)
WO (2) WO2009112874A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20151323A1 (es) * 2012-09-26 2015-10-10 Eurodrug Lab B V Metadoxina para usarse en el tratamiento de enfermedades hepaticas y formulaciones de liberacion prolongada de metadoxina
CN103524503B (zh) * 2013-10-29 2014-08-06 天津梅花医药有限公司 多索茶碱半水化合物
CN110898019A (zh) * 2019-12-19 2020-03-24 上海宣泰海门药业有限公司 多索茶碱片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58501128A (ja) * 1981-07-15 1983-07-14 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 徐放性テオフイリン
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US5196203A (en) * 1989-01-06 1993-03-23 F. H. Faulding & Co. Limited Theophylline dosage form
US5858411A (en) * 1994-12-19 1999-01-12 Daiichi Pharmaceutical Co., Ltd. Sustained-release granular preparations and production process thereof
MXPA04011335A (es) * 2002-05-16 2005-07-01 Pharmacia Corp Metodos para el tratamiento de enfermedades y afecciones respiratorias con un inhibidor selectivo de inos y un inhibidor de pde y composiciones para esto.
US7511159B2 (en) * 2003-12-25 2009-03-31 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
EA012615B1 (ru) * 2005-02-22 2009-10-30 Пфайзер Инк. Производные оксииндола в качестве агонистов 5-htрецептора
WO2007120485A2 (en) * 2006-03-30 2007-10-25 Cinergen, Llc Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
CN100536849C (zh) * 2006-05-10 2009-09-09 鲁南制药集团股份有限公司 含有茶碱类药物和维生素k的药物组合物
WO2008033351A2 (en) * 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
CN101028254B (zh) * 2007-04-05 2010-05-19 合肥合源医药科技股份有限公司 一种多索茶碱缓释制剂及其制备方法

Also Published As

Publication number Publication date
MX2010009917A (es) 2010-12-21
KR101697773B1 (ko) 2017-01-18
BRPI0906158B1 (pt) 2021-01-05
ITMI20080798A1 (it) 2009-09-11
BRPI0906158B8 (pt) 2021-05-25
AU2009224801A1 (en) 2009-09-17
AU2009224801B2 (en) 2014-06-05
WO2009112874A1 (en) 2009-09-17
EP2262485A1 (en) 2010-12-22
BRPI0906158A2 (pt) 2017-07-18
WO2009112436A1 (en) 2009-09-17
KR20100124860A (ko) 2010-11-30

Similar Documents

Publication Publication Date Title
MX2010004323A (es) Formas de dosificacion oral que comprenden acetato de licarbazepina.
HK1190909A1 (zh) 用於鼻淚系統的藥物釋放方法、結構及組合物
SG169353A1 (en) Tamper resistant dosage forms
JO3757B1 (ar) التركيبات الصيدلانية التي تشمل على نيلوتينيب أو أملاحه
IL205360A0 (en) Methods, kits, and compositions for administering pharmaceutical compounds
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
MX343358B (es) Tabletas de acetato de ulipristal.
HK1172845A1 (en) Novel pharmaceutical formulations against drug misuse
WO2009071690A3 (de) 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
AP2011005687A0 (en) Sustained release drug delivery system.
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
TN2011000651A1 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application
TR200904159A1 (tr) Değiştirilmiş salım sağlayan emoksipin formülasyonları.
EA200900958A1 (ru) Препарат невирапина пролонгированного высвобождения
EP2292242A4 (en) SCUTELLARIN DERIVATIVE, PROCESS FOR PREPARING, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
ATE479427T1 (de) Pharmazeutische zusammensetzung mit candesartan- cilexetil
WO2011014003A3 (en) (+)-3-hydroxymorphinan derivatives as neuroprotectants
EP2264031A4 (en) Novel benzoxazine-benzimidazole derivative, pharmaceutical composition therefor and use thereof
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
MX2008010233A (es) Composicion de liberacion modificada, que comprende doxofilina.
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
EP2292241A4 (en) SCUTELLARIN DERIVATIVE PRODUCTION, PREPARATION, PHARMACEUTICAL COMPOSITION AND ITS USE
TW200833359A (en) Elution-improved pharmaceutical preparation

Legal Events

Date Code Title Description
FG Grant or registration